Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-04 · accession 0001668397-24-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-06 | 2024-03-04+ | MEDP | GEIGER JESSE J | Pres | M - OptEx | $90.65 | +40.0K | 21.5K | New | +$3.63M |
| D | 2024-03-06 | 2024-03-04 | MEDP | GEIGER JESSE J | Pres | S - Sale+OE | $403.03 | -22.3K | 3,824 | -85% | -$9.00M |
| DM | 2024-03-06 | 2024-03-04+ | MEDP | GEIGER JESSE J | Pres | M - OptEx | $0.00 | -40.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-04 | M | A | 22,321 | $90.65 | 26,145 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-04 | S | D | 22,321 | $403.03 | 3,824 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $401.60 to $404.525. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| 3 | Common | Common Stock | 2024-03-05 | M | A | 17,679 | $90.65 | 21,503 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2024-03-04 | M | D | 22,321 | $0.00 | 17,679 | D | $90.65 · — to 2024-08-05 | 22,321 Common Stock | (F3) The option vested in full on August 5, 2019. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2024-03-05 | M | D | 17,679 | $0.00 | 0 | D | $90.65 · — to 2024-08-05 | 17,679 Common Stock | (F3) The option vested in full on August 5, 2019. |